发明名称 Insulin derivatives with increased zinc binding.
摘要 Insulin of formula (I): R1 is H or Phe; R3, Y are genetically encodable amino acids; Z = His or a peptide chain of 2-35 genetically encodable amino acids including 1-5 His residues; A2-A20 (not shown) correspond to the amino acid sequence of the A chain of human insulin, an animal insulin or an insulin derivative; B2-B29 (not shown) correspond to the amino acid sequence of the B chain of human insulin, an animal insulin or an insulin derivative. Also claimed are: (1) a complex comprising an insulin hexamer and 5-9 zinc atoms per insulin hexamer, where the hexamer consists of six insulin molecules of formula (I); (2) proinsulin of formula (II): R2-R1'-B2-B29-Y-Z1-Gly-A2-A20-R3 (II) R1' = Phe or a covalent bond; R2 = a genetically encodable amino acid or a peptide chain of 2-45 amino acids, and Z1 is a peptide chain of 2-40 genetically encodable amino acids including 1-5 His residues.
申请公布号 ZA9706645(B) 申请公布日期 1998.01.26
申请号 ZA19970006645 申请日期 1997.07.25
申请人 HOECHST AKTIENGESELLSCHAFT 发明人 JOHANN ERTL;PAUL HABERMANN;KARL GEISEN;GERHARD SEIPKE
分类号 C07K14/575;A61K38/00;A61K38/28;A61P3/08;A61P5/50;C07K14/62 主分类号 C07K14/575
代理机构 代理人
主权项
地址
您可能感兴趣的专利